Alexander Varond is a partner in Goodwin’s Technology and Life Sciences groups and a co-chair of the firm’s FDA Litigation practice. Mr. Varond advises drug, biotech, and device clients on a wide range of FDA regulatory matters. He has extensive experience in medical device and drug development, Hatch-Waxman patent and exclusivity issues, and regulatory strategy. Mr. Varond also counsels on advertising and promotional issues, defends companies during civil and criminal investigations on a variety of issues, including off-label promotion and GMPs, and regularly advises on corporate transactions. 

Prior to joining Goodwin in 2017, Mr. Varond was a senior associate at Hyman, Phelps & McNamara, PC. His perspective is bolstered by having worked closely alongside numerous in-house regulatory and legal teams through various critical projects, including NDA preparation, formal dispute resolutions, FDA and regulatory strategy advisory meetings, and product launches.

Areas of Practice
Domaines D’Expertise





Professional Activities

Mr. Varond serves as a board member of the NAA10 Foundation, a patient advocacy group dedicated to supporting families with NAA10. He is a member of several industry groups, including the Food and Drug Law Institute and the Drug Information Association. He previously served on the Food and Drug Law Institute’s Drug & Biologics Committee. Mr. Varond is also an active member of the Asian Pacific American Bar Association.

Professional Experience

Mr. Varond's professional experience includes roles as a medical device engineer, operations manager, and deputy management representative to FDA in the medical device industry. He also served as an intellectual property law clerk at NuVasive, Inc.

In 2010, Mr. Varond externed at the International Trade Commission’s Office of Unfair Imports and Investigations.


Mr. Varond has been recognized by The Best Lawyers in America Best Lawyers for his work in FDA Law 2022. 

In 2018, Mr. Varond received LMG Life Science’s U.S. Regulatory Rising Star Award. He is also recognized on the 2019-2021 Washington, D.C., Super Lawyers list of “Rising Stars” in Food & Drug Law. In addition, Mr. Varond has been consistently recognized in The Legal 500 United States for his work in the life sciences industry, specifically in FDA law. Mr. Varond was named to The Best Lawyers in America 2021: Ones to Watch. He is also listed as a “Rising Star” in Euromoney’s 2020 and 2021 Expert Guides.

In law school, Mr. Varond placed second in the nation in the 2010-2011 National Giles S. Rich Intellectual Property Moot Court Competition. He was also named Best Overall Competitor and won the award for Best Brief for his efforts in The George Washington Law School's intellectual property moot court competition in 2011. In addition, he was a member of the Moot Court Board and Alternative Dispute Resolution Board.

In The News









J.D., 2011
The George Washington University Law School
B.S., Biomedical Engineering and Management Science, 2006
University of California, San Diego



District of Columbia
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique